Gara Jalqabaatti › Kansaar Onnee Triple-Negative › Ohio › Columbus
Qorannoo klinikaalii Kansaar Onnee Triple-Negative Columbus, OH keessatti
Qorannoo 16 Kansaar Onnee Triple-Negative f Columbus fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Ohio State University Comprehensive Cancer Center, Columbus
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Namoota walitti qabaa jiraQorannoo ilaalaa
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Local Institution - 0102, Columbus
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Ohio State University, Columbus
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Namoota walitti qabaa jiraSadarkaa 3
- Ohio State University CRS, Columbus
- Ohio Health Research Institute, Columbus
- Anita Stewart Oncology Center, Columbus
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- The Ohio State University (OSU) Wexner Medical Center, Columbus
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- The Ohio State University, Columbus
SMP-3124LP in Adults With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Ohio State University, Columbus
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Namoota walitti qabaa jiraSadarkaa 1/2
- Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer
Namoota walitti qabaa jira
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of LY4175408 in Participants With Advanced Cancer
Namoota walitti qabaa jiraSadarkaa 1
- The Ohio State University (OSU) Wexner Medical Center, Columbus
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Namoota walitti qabaa jiraSadarkaa 2
- Ohio State University Medical Center, Columbus
Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer
Namoota walitti qabaa jira
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Namoota walitti qabaa jiraSadarkaa 1/2
- The Ohio State University, Columbus
Qorannoo Kansaar Onnee Triple-Negative magaalota biroo keessatti
- Houston, TXQorannoo 42
- New York City, NYQorannoo 31
- Nashville, TNQorannoo 28
- Los Angeles, CAQorannoo 27
- Boston, MAQorannoo 26
- San Antonio, TXQorannoo 23
- St. Louis, MOQorannoo 21
- Arlington, VAQorannoo 20
- Atlanta, GAQorannoo 20
- Dallas, TXQorannoo 18
- Chicago, ILQorannoo 16
- Grand Rapids, MIQorannoo 15
Qorannoo biroo Columbus keessatti
- Kansara Qara'a Non-Small CellQorannoo 57
- Saree OljooQorannoo 40
- Kansarii OvariiQorannoo 39
- Saree (Gosoota Hunda)Qorannoo 38
- Dhibee QaraQorannoo 37
- Leukemia Myeloidii HamaaQorannoo 35
- Luukemiya Limfoositiikii KeessummaaQorannoo 28
- Kansara MetastatikiiQorannoo 27
- Kansa EndometiriyaaliiQorannoo 25
- Kansarii ProstateQorannoo 24
- Myeloma Baay’eeQorannoo 24
- Kansarii ColorectalQorannoo 24
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.